Suche
Kategorie
Erscheinungsjahr
1662 Treffer
×
Publikationen
×
2022
×
Johannes Gutenberg-Universität Mainz
×
Universität Koblenz
×
Hochschule Trier
×
Theologische Fakultät Trier
×
Hochschule Koblenz
- Kundu, Nisha; Kothari, Rohit; Shah, Nimish et al.
- Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring
- JOURNAL OF COSMETIC DERMATOLOGY. 2022
- Bhatt, Siddharth; Kothari, Rohit; Tripathy, Durga Madhab et al.
- Emerging drugs for the treatment of acne: a review of phase 2 & 3 trials
- EXPERT OPINION ON EMERGING DRUGS. 2022
- Wegner, Erik; Slotina, Ekaterina; Mickan, Tim et al.
- Pleiotropic Long-Term Effects of Atorvastatin on Posttraumatic Joint Contracture in a Rat Model
- PHARMACEUTICS. Bd. 14. H. 3. 2022
- Medina-Montano, Carolina; Rivero Berti, Ignacio; Gambaro, Rocio C. et al.
- Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells
- PHARMACEUTICS. Bd. 14. H. 8. 2022
- Cacicedo, Maximiliano L.; Weinl-Tenbruck, Christine; Frank, Daniel et al.
- mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model
- MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. Bd. 26. 2022 S. 294-308
- Hennermann, Julia B.; Raebel, Eva M.; Dona, Francesca et al.
- Mortality in patients with alpha-mannosidosis: a review of patients' data and the literature
- ORPHANET JOURNAL OF RARE DISEASES. Bd. 17. H. 1. 2022
- Berner, Reinhard; Hansen, Gesine; Kerbl, Reinhold et al.
- Monthly Journal of Pediatrics thanks the Reviewers 2021
- MONATSSCHRIFT KINDERHEILKUNDE. Bd. 170. H. 1. 2022 S. 1-2
- Hoffmann, Florian; Zepp, Fred
- Pediatric Emergencies
- MONATSSCHRIFT KINDERHEILKUNDE. Bd. 170. H. 7. 2022 S. 586-587
- Czysch, Christian; Medina-Montano, Carolina; Zhong, Zifu et al.
- Transient Lymph Node Immune Activation by Hydrolysable Polycarbonate Nanogels
- ADVANCED FUNCTIONAL MATERIALS. 2022
- Haist, Maximilian; Stege, Henner; Ebner, Ronja et al.
- The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort Study
- CANCERS. Bd. 14. H. 9. 2022